Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

CDC Issues Updated Recommendations for VariZIG (FREE)
By Amy Orciari Herman The CDC has issued updated recommendations for the use of VariZIG, the varicella-zoster immunoglobulin given for postexposure prophylaxis in high-risk patients and for whom the varicella vaccine is contraindicated. As reported in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 19, 2013 Category: Primary Care Source Type: news

Vaccination Against Herpes Zoster and Postherpetic NeuralgiaVaccination Against Herpes Zoster and Postherpetic Neuralgia
Is herpes zoster vaccination worth the cost? Expert Review of Pharmacoeconomics & Outcomes Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 18, 2013 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news

Shingles vaccine programme revealed
A universal routine herpes zoster (shingles) vaccination programme for adults over 70 years old is due to begin in September 2013, the government has announced Hide related content: Show related content read more (Source: Management in Practice)
Source: Management in Practice - July 17, 2013 Category: Practice Management Authors: lspringer Tags: *** Editor ' s Pick *** Featured Patients Latest News Source Type: news

Dr. Anne Gershon receives 2013 Albert B. Sabin Gold Medal Award
(Sabin Vaccine Institute) Today, the Sabin Vaccine Institute presented its annual Albert B. Sabin Gold Medal Award to Dr. Anne Gershon, of Columbia University, for her outstanding research and public health efforts to combat the varicella zoster virus. Dr. Gershon's research was critical to the widespread adoption of the varicella vaccine, which prevents chickenpox. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2013 Category: Global & Universal Source Type: news

Shingles Vaccine Effective but Underused in Elderly Shingles Vaccine Effective but Underused in Elderly
Incidence of herpes zoster and postherpetic neuralgia was markedly lower in people who were immunized, but 96% of the study population had not received the vaccine. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Study Finds Shingles Vaccine Effective, But Uptake Remains Low
When it comes to protecting older patients from the ravages of shingles and its sequelae, family physicians have no better weapon in their arsenal than the herpes zoster vaccine. But, like every other vaccine, it only works if patients get it. Unfortunately, a recent study found that despite the documented effectiveness of the herpes zoster vaccine in preventing shingles and its most common complication -- postherpetic neuralgia -- few people are receiving the immunization. (Source: AAFP Health of the Public)
Source: AAFP Health of the Public - April 11, 2013 Category: Primary Care Source Type: news

Shingles Vaccine Is Associated With Reduction In Both Postherpetic Neuralgia And Herpes Zoster, But Uptake In The US Is Low
A vaccine to prevent shingles may reduce by half the occurrence of this painful skin and nerve infection in older people (aged over 65 years) and may also reduce the rate of a painful complication of shingles, post-herpetic neuralgia, but has a very low uptake (only 4%) in older adults in the United States, according to a study by UK and US researchers published in this week's PLOS Medicine... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Varicella Vaccine Has Long-Term Effectiveness Against Chicken Pox
Chicken pox, the childhood affliction of earlier generations, has been largely neutralized by the varicella vaccine, according to a new study by the Kaiser Permanente Vaccine Study Center, which appears in the current online issue of Pediatrics. The 14-year study followed 7,585 children who were vaccinated in 1995, when they were 12 to 23 months old, to assess the long-term effectiveness of the vaccine and the impact on the epidemiology of varicella (chicken pox) and herpes zoster (shingles). Researchers also observed the impact of the second dose of varicella vaccine, introduced in 2006... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 4, 2013 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Varicella Vaccine Has Long-Lasting Effectiveness Against Chickenpox
Chickenpox, the childhood infection of earlier generations, has been most recently neutralized by the varicella vaccine - a vaccine that has shown long-term effectiveness against the illness, according to a new study by the Kaiser Permanente Vaccine Study Center. The study findings, published in the journal Pediatrics, were based on a 14-year study consisting of 7,585 children ranging in age from 12 to 23 months. The researchers aimed to examine the long-term effectiveness of the vaccine and its influence on the epidemiology of varicella (chickenpox) and herpes zoster (shingles)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 2, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Chickenpox Vaccine Effective For A Long Time
Chickenpox, the childhood infection of earlier generations, has been most recently neutralized by the varicella vaccine - a vaccine that has shown long-term effectiveness against the illness, according to a new study by the Kaiser Permanente Vaccine Study Center. The study findings, published in the journal Pediatrics, were based on a 14-year study consisting of 7,585 children ranging in age from 12 to 23 months. The researchers aimed to examine the long-term effectiveness of the vaccine and its influence on the epidemiology of varicella (chickenpox) and herpes zoster (shingles)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 2, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Depression reduces efficacy of shingles vaccine
Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression. (Source: MedWire News - Dermatology)
Source: MedWire News - Dermatology - February 16, 2013 Category: Dermatology Source Type: news

UCLA study suggests link between untreated depression, response to shingles vaccine
Can an individual's state of mind effect how well a vaccine may work? In the case of seniors and shingles, the answer is yes. Reporting in the current online edition of the journal Clinical Infectious Diseases, Dr. Michael Irwin, a professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA, demonstrates a link between untreated depression in older adults and decreased effectiveness of the herpes zoster —or shingles — vaccine. Shingles is a painful, blistering skin rash that can last for months or even years. It's caused by the varicella–zoster virus, the ...
Source: UCLA Newsroom: Health Sciences - February 16, 2013 Category: Universities & Medical Training Source Type: news

Depression reduces efficacy of shingles vaccine
Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression. (Source: MedWire News - Psychiatry)
Source: MedWire News - Psychiatry - February 15, 2013 Category: Psychiatry Source Type: news

Treating Depression May Boost Vaccine ResponseTreating Depression May Boost Vaccine Response
Treating major depression in older adults may significantly boost their response to vaccines, such as for herpes zoster. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Depression May Lower Response to Shingles Vax (CME/CE)
(MedPage Today) -- Untreated major depression may hamper the protective effect of varicella zoster virus vaccine against herpes zoster -- shingles -- in older individuals, researchers found. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - February 14, 2013 Category: Consumer Health News Source Type: news